Literature DB >> 20351099

Altered linkage of hydroxyacyl chains in lipid A of Campylobacter jejuni reduces TLR4 activation and antimicrobial resistance.

Andries van Mourik1, Liana Steeghs, Jacoline van Laar, Hugo D Meiring, Hendrik-Jan Hamstra, Jos P M van Putten, Marc M S M Wösten.   

Abstract

Modification of the lipid A moiety of bacterial lipopolysaccharide influences cell wall properties, endotoxic activity, and bacterial resistance to antimicrobial peptides. Known modifications are variation in the number or length of acyl chains and/or attached phosphoryl groups. Here we identified two genes (gnnA and gnnB) in the major foodborne pathogen Campylobacter jejuni that enable the synthesis of a GlcN3N precursor UDP 2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose (UDP-GlcNAc3N) in the lipid A backbone. Mass spectrometry of purified lipooligosaccharide verified that the gene products facilitate the formation of a 2,3-diamino-2,3-dideoxy-D-glucose (GlcN3N) disaccharide lipid A backbone when compared with the beta-1'-6-linked D-glucosamine (GlcN) disaccharide observed in Escherichia coli lipid A. Functional assays showed that inactivation of the gnnA or gnnB gene enhanced the TLR4-MD2-mediated NF-kappaB activation. The mutants also displayed increased susceptibility to killing by the antimicrobial peptides polymyxin B, colistin and the chicken cathelicidin-1. The gnnA and gnnB genes are organized in one operon with hemH, encoding a ferrochelatase catalyzing the last step in heme biosynthesis. These results indicate that lipid A modification resulting in amide-linked acyl chains in the lipid A is an effective mechanism to evade activation of the innate host defense and killing by antimicrobial peptides.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351099      PMCID: PMC2871450          DOI: 10.1074/jbc.M110.102061

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Diversity of endotoxin and its impact on pathogenesis.

Authors:  M Stephen Trent; Christopher M Stead; An X Tran; Jessica V Hankins
Journal:  J Endotoxin Res       Date:  2006

2.  Ligand-induced differential cross-regulation of Toll-like receptors 2, 4 and 5 in intestinal epithelial cells.

Authors:  Rémon A M H van Aubel; A Marijke Keestra; Daniëlle J E B Krooshoop; Willem van Eden; Jos P M van Putten
Journal:  Mol Immunol       Date:  2007-05-09       Impact factor: 4.407

3.  Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.

Authors:  Ho Min Kim; Beom Seok Park; Jung-In Kim; Sung Eun Kim; Judong Lee; Se Cheol Oh; Purevjav Enkhbayar; Norio Matsushima; Hayyoung Lee; Ook Joon Yoo; Jie-Oh Lee
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

4.  Unique properties of the chicken TLR4/MD-2 complex: selective lipopolysaccharide activation of the MyD88-dependent pathway.

Authors:  A Marijke Keestra; Jos P M van Putten
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

5.  A novel secondary acyl chain in the lipopolysaccharide of Bordetella pertussis required for efficient infection of human macrophages.

Authors:  Jeroen Geurtsen; Eline Angevaare; Marlieke Janssen; Hendrik-Jan Hamstra; Jan ten Hove; Alex de Haan; Betsy Kuipers; Jan Tommassen; Peter van der Ley
Journal:  J Biol Chem       Date:  2007-10-29       Impact factor: 5.157

6.  Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis.

Authors:  Liana Steeghs; A Marijke Keestra; Andries van Mourik; Heli Uronen-Hansson; Peter van der Ley; Robin Callard; Nigel Klein; Jos P M van Putten
Journal:  Infect Immun       Date:  2008-05-19       Impact factor: 3.441

7.  Lipopolysaccharide bound structures of the active fragments of fowlicidin-1, a cathelicidin family of antimicrobial and antiendotoxic peptide from chicken, determined by transferred nuclear Overhauser effect spectroscopy.

Authors:  Anirban Bhunia; Harini Mohanram; Surajit Bhattacharjya
Journal:  Biopolymers       Date:  2009       Impact factor: 2.505

Review 8.  Lipid A modification systems in gram-negative bacteria.

Authors:  Christian R H Raetz; C Michael Reynolds; M Stephen Trent; Russell E Bishop
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

9.  Functional analysis of a Campylobacter jejuni alkaline phosphatase secreted via the Tat export machinery.

Authors:  Andries van Mourik; Nancy M C Bleumink-Pluym; Linda van Dijk; Jos P M van Putten; Marc M S M Wösten
Journal:  Microbiology       Date:  2008-02       Impact factor: 2.777

10.  Re-annotation and re-analysis of the Campylobacter jejuni NCTC11168 genome sequence.

Authors:  Ozan Gundogdu; Stephen D Bentley; Matt T Holden; Julian Parkhill; Nick Dorrell; Brendan W Wren
Journal:  BMC Genomics       Date:  2007-06-12       Impact factor: 3.969

View more
  25 in total

1.  Altered linkage of hydroxyacyl chains in bacterial lipid A.

Authors:  Anthony P Moran
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

2.  Campylobacter jejuni induces extra-intestinal immune responses via Toll-like-receptor-4 signaling in conventional IL-10 deficient mice with chronic colitis.

Authors:  B Otto; L-M Haag; A Fischer; R Plickert; A A Kühl; U B Göbel; M M Heimesaat; S Bereswill
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

Review 3.  Lipid A structural modifications in extreme conditions and identification of unique modifying enzymes to define the Toll-like receptor 4 structure-activity relationship.

Authors:  Alison J Scott; Benjamin L Oyler; David R Goodlett; Robert K Ernst
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-01-17       Impact factor: 4.698

Review 4.  Polymyxin: Alternative Mechanisms of Action and Resistance.

Authors:  Michael J Trimble; Patrik Mlynárčik; Milan Kolář; Robert E W Hancock
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

5.  Campylobacter jejuni lipooligosaccharide sialylation, phosphorylation, and amide/ester linkage modifications fine-tune human Toll-like receptor 4 activation.

Authors:  Holly N Stephenson; Constance M John; Neveda Naz; Ozan Gundogdu; Nick Dorrell; Brendan W Wren; Gary A Jarvis; Mona Bajaj-Elliott
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

Review 6.  How a sugary bug gets through the day: recent developments in understanding fundamental processes impacting Campylobacter jejuni pathogenesis.

Authors:  Christine M Szymanski; Erin C Gaynor
Journal:  Gut Microbes       Date:  2012-03-01

7.  Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections.

Authors:  Soraya Mousavi; Stefan Bereswill; Markus M Heimesaat
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

8.  The polysaccharide capsule of Campylobacter jejuni modulates the host immune response.

Authors:  Alexander C Maue; Krystle L Mohawk; David K Giles; Frédéric Poly; Cheryl P Ewing; Yuening Jiao; Ginyoung Lee; Zuchao Ma; Mario A Monteiro; Christina L Hill; Jason S Ferderber; Chad K Porter; M Stephen Trent; Patricia Guerry
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

9.  The lipopolysaccharide modification regulator PmrA limits Salmonella virulence by repressing the type three-secretion system Spi/Ssa.

Authors:  Jeongjoon Choi; Eduardo A Groisman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

10.  EptC of Campylobacter jejuni mediates phenotypes involved in host interactions and virulence.

Authors:  Thomas W Cullen; John P O'Brien; David R Hendrixson; David K Giles; Rhonda I Hobb; Stuart A Thompson; Jennifer S Brodbelt; M Stephen Trent
Journal:  Infect Immun       Date:  2012-11-26       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.